Advrt News Today

British consumers buying cryptoassets will get a 24-hour "cooling-off" period for the first time from October under tougher marketing rules unveiled by the financial regulator on Thursday.

China's cyberspace regulator said 1.4 million social media posts have been deleted following a two-month probe into alleged misinformation, illegal profiteering, and impersonation of state officials, among other "pronounced problems".

Russian state-owned bank VTB will launch a digital bank within the mobile messaging app of leading social network VKontakte, Russia's answer to Facebook, as Moscow seeks technological solutions to disrupted banking transfers.

Chinese social media giant Weibo Corp's shares closed 7.2% below their issue price in Hong Kong on Wednesday, as it became the latest U.S.-listed China stock to seek out a secondary listing closer to home.

Russian billionaire Alisher Usmanov's USM holding said on Thursday it had sold its stake in VK Group, formerly known as Mail.RU , to the SOGAZ state-controlled insurance company.

Chinese social media firm Weibo Corp plans to price its shares at HK$272.8 ($35.01) each to raise $385 million in its Hong Kong secondary listing, said three sources with direct knowledge of the matter.

U.S. tech giants will have to provide more data on their targeted political ads or risk fines up to 4% of their global turnover under draft EU rules seen by Reuters, part of the bloc's crackdown on misinformation during elections.

Russia's largest lender Sberbank and internet firm Mail.Ru have invested an additional 12.2 billion roubles ($168.39 million) in their ride-hailing and food delivery joint venture, the companies said on Thursday.

The man accused of mowing down a Muslim family with his pickup truck in what Canadian police are calling a hate-motivated attack appeared briefly by Zoom before a judge on Thursday and is due back early next week.

An official Canadian panel on Tuesday said people who received a first shot of AstraZeneca PLC's (AZN.L) COVID-19 vaccine can choose to receive a different shot for their second dose, dealing another potential blow to the pharmaceutical giant.